Cargando…
The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study
A growing number of studies have shown that brain-derived neurotrophic factor (BDNF) is associated with weight gain during antipsychotic treatment in schizophrenia patients. However, there is still a lack of research results in the initial stage of antipsychotic treatment. This study aimed to evalua...
Autores principales: | Liu, Jiahong, Wang, Pingping, Sun, Leilei, Guan, Xiaoni, Xiu, Meihong, Zhang, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418607/ https://www.ncbi.nlm.nih.gov/pubmed/34482368 http://dx.doi.org/10.1038/s41398-021-01585-3 |
Ejemplares similares
-
BDNF Val66Met Variant and Smoking in a Chinese Population
por: Zhang, Xiang Yang, et al.
Publicado: (2012) -
Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
por: Youssef, Mariam M, et al.
Publicado: (2018) -
Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia
por: Su, Xiuru, et al.
Publicado: (2021) -
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid
por: Cattaneo, Annamaria, et al.
Publicado: (2010) -
Association between the BDNF Val66Met Polymorphism and Chronicity of Depression
por: Lee, Yujin, et al.
Publicado: (2013)